scholarly journals Effect of Abdominal Breathing Combined with Brisk Walking on Intervention Effect of Female Patients with Essential Hypertension

2021 ◽  
Vol 13 (3) ◽  
pp. 76
Author(s):  
Bing Zhao ◽  
Haixia Wang

OBJECTIVE: Exploring the intervention effect of abdominal breathing combined with brisk walking on female patients with essential hypertension. METHODS: 98 female patients diagnosed as essential hypertension were randomly divided into simple walking group and abdominal breathing combined with walking group, and the intervention effects of the two groups were compared. RESULTS: Abdominal breathing combined with brisk walking was better than brisk walking alone in BMI, systolic blood pressure, total cholesterol, low density lipoprotein and other aspects (P<0.05). CONCLUSION: Abdominal breathing combined with brisk walking exercise can improve the therapeutic effect of female patients with essential hypertension and improve their self-management ability for chronic diseases.

1993 ◽  
Vol 11 (10) ◽  
pp. 1103-1111 ◽  
Author(s):  
Elena Maggi ◽  
Eugenia Marchesi ◽  
Valentina Ravetta ◽  
Francesco Falaschi ◽  
Giorgio Finardi ◽  
...  

Hypertension ◽  
2014 ◽  
Vol 64 (suppl_1) ◽  
Author(s):  
Tong Yin ◽  
Yusong Zhang ◽  
Xi Chen ◽  
Jie Yang ◽  
Yuxiao Zhang ◽  
...  

BACKGROUND: The mitochondrial genetic variant of nicotinamide adenine dinucleotide dehydrogenase subunit-2 (ND2) 5178C>A (Leu237Met) was previously found to have a protective effect against essential hypertension (EH) in Chinese and Japanese populations. AIM: The present study aimed to determine whether the protective effect of ND2 5178C>A against EH is associated with the mitochondrial heteroplasmy level of the variant. METHODS: This case-control study involved 109 unrelated Chinese-Han matched pairs of essential hypertension and healthy normotensive controls. All consented subjects were recruited consecutively from Institute of Geriatric Cardiology and Health Examination Center in General Hospital of Chinese People’s Liberation Army from February 2013 to January 2014. Demographic and clinical characteristics were recorded. Mitochondrial DNA was isolated from the blood leukocytes for each subject. The level of heteroplasmy for 5178C>A variant occurring in the coding region of ND2 was quantified using real-time polymerase chain reaction (PCR) method. RESULTS: The ND2 5178C>A heteroplasmy level ranged between 27% and 77%, with a median level of 44%. Between the upper and lower quartiles of 5178C>A heteroplasmy distribution, significant differences were observed for systolic blood pressure (116±17 vs. 129±25 mmHg, P=0.004) , body mass index (BMI) (24.6±3.3 vs.26.5±3.6, P=0.008) , total cholesterol (4.0±0.8 vs. 3.4±0.9 mmol/L, P<0.001) , low density lipoprotein (2.5±0.7 vs. 1.5±0.7 mmol/L, P<0.001) and triglyceride levels (1.8±1.6 vs. 4.0±1.6 mmol/L, P<0.001). ND2 5178C>A heteroplasmic level was negatively correlated with the presence of hypertension (r = -0.38, P < 0.001), BMI (r = -0.19, P = 0.007), and the level of total cholesterol (r = -0.18, P = 0.01). Logistic regression analysis showed that participants with higher ND2 5178C>A heteroplasmy level (≥44%) were found to have significantly lower prevalence of essential hypertension (29%, 32 in 109), as compared to those with lower (< 44%) ND2 5178C>A heteroplasmy level (71%, 77 in 109) (OR: 0.18, 95% CI: 0.10-0.31, P<0.001). CONCLUSION: The protective effect of mitochondrial ND2 5178C>A against EH is associated with the heteroplasmy level of the variant.


1995 ◽  
Vol 13 (1) ◽  
pp. 129???138 ◽  
Author(s):  
Elena Maggi ◽  
Eugenia Marchesi ◽  
Valentina Ravetta ◽  
Alessandra Martignoni ◽  
Giorgio Finardi ◽  
...  

2015 ◽  
Vol 16 (1) ◽  
pp. 14-17
Author(s):  
Nwamaka Chiji Okenzere ◽  
Chukwubike Udoka Okeke

Objective: Patients with chronic renal failure have high burden of cardiovascular morbidity and mortality. This study was carried out to investigate the development of cardiovascular disease in chronic renal failure among female patients on dialysis treatment in Nigeria. Materials and Methods: A total of 40 adult female subjects participated in this study. 20 of them were apparently healthy and served as control group while the rest 20 were female patients with chronic renal failure (CRF) on dialysis treatment. Fasting blood samples were collected and their lipid profile, Total Cholesterol (TC), Triglyceride (TG), High Density Lipoprotein –Cholesterol (HDL-C), Low Density Lipoprotein –Cholesterol (LDL-C), and Very Low Density Lipoprotein –Cholesterol (VLDL-C) were estimated using enzymatic methods. The percentages of these parameters in circulation were obtained. The cardiovascular risk ratios (TC/HDL-C and LDL-C/HDL-C) were calculated. Result: The lipid profile of the chronic renal failure patients (TC 5.70±0.80mmol/l, TG 1.46±0.40mmol/l, LDL-C 3.50±0.2mmol/l, and VLDL-C 0.67±0.2mmol/l) were significantly higher (p<0.05) than that of control group (TC 4.03±0.13mmol/l, TG 1.10± 0.3mmol/l , LDL-C 1.85±0.5mmol/l, and VLDL-C 0.50± 0.01mmol/l) except HDL-C. HDL-C of the CRF patients (1.40±0.2mmol/l) was significantly lower (p<0.05) than that of healthy women (HDL-C 1.70± 0.04mmol/l). These depict no difference in the percentage of VLDL-C & TG in circulation between the control (VLDL –C 5% and TG 45%) and chronic renal failure patients (VLDL –C 5% and TG 44%). In CRF group, it was observed that 28% of the total plasma lipid (12.73mmol/l) was LDL-C but in healthy women, percentage of LDL-C in circulation (out of 9.18mmol/l) was 20%. It was also observed that 11% of the total plasma lipid (12.73mmol/l) in CRF patients was HDL-C but in healthy subjects, the percentage of HDL-C in circulation (out of 9.18mmol/l) was 19%. The cardiovascular risk indices (TC/HDL-C and LDL-C/HDL-C) of the CRF patients (TC/HDL-C 3.91±0.24 and LDL-C/HDL-C 2.50±0.01) were significantly higher (p<0.05) than those of the healthy subjects (TC/HDL-C 2.40±0.09, LDL-C/HDL-C 1.10±0.08). Conclusion: These results indicate that chronic renal failure is a risk factor to development of cardiovascular disease in female patients on dialysis.DOI: http://dx.doi.org/10.3329/jom.v16i1.22382 J MEDICINE 2015; 16 : 14-17


Sign in / Sign up

Export Citation Format

Share Document